THAR
Tharimmune, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.54
+6.63%Latest reported
- Last report date
- Mar 24, 2026
- EPS actual
- -$2.02
- EPS estimate
- -$0.42
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -100.6%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 24, 2026